These will be used to isolate and sequence single cells from tumors and metastatic sites by JAE young so and abdul ahad

Ended Awarded Last action

Contract number
75N91022F00007
Awardee
Awarding agency
Obligated
$15,151

Award facts

Contract value 100% obligated
$15,150.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute issued a BPA call to 10X Genomics, Inc. valued at $15,150.50 on August 28, 2022. The call is for single-cell isolation and sequencing reagents and consumables to support tumor and metastatic site analysis by named researchers (Jae Young So and Abdul Ahad). Performance occurs at 10X Genomics' facility in Pleasanton, California, with completion targeted for September 27, 2022. The call carries firm fixed pricing and no set-aside designation.

Quick answers

Who was awarded contract 75N91022F00007?

75N91022F00007 was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on August 28, 2022.

How much is contract 75N91022F00007 worth?

The government has obligated $15,151 on 75N91022F00007.

Is contract 75N91022F00007 an order under another contract?

Yes. 75N91022F00007 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N91022F00007 competed?

The extent of competition for 75N91022F00007 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login